Microfluidic apparatus and method for synthesis of molecular imaging probes

• US 20050232387A1
• Filed: 04/20/2004
• Published: 10/20/2005
• Est. Priority Date: 04/20/2004
• Status: Abandoned Application

• Current Assignee: Molecular Technologies
• Original Assignee: Molecular Technologies
• Inventors: Alvord, Charles W., Matteo, Joseph C., Collier, Thomas Lee, Padgett, Henry C., Buchanan, Charles Russell
• Application Number:
  US10/827,893
• Publication Number:
  US 20050232387A1
• Time in Patent Office: Days
• US Class Current: 376/194
• CPC Class Codes: A61K 51/0491 Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Abstract

The invention provides a method and apparatus for preparation of radiochemicals, such as PET molecular imaging probes, wherein the reaction step or steps that couple the radioactive isotope to an organic or inorganic compound to form a positron-emitting molecular imaging probe are performed in a microfluidic environment. The method for synthesizing a radiochemical in a microfluidic environment comprises: i) providing a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port; ii) introducing a reactive precursor into the first inlet port of the micro reactor, the reactive precursor adapted for reaction with a radioactive isotope to form a radiochemical; iii) introducing a solution comprising a radioactive isotope into the second inlet port of the micro reactor; iv) contacting the reactive precursor with the isotope-containing solution in the microchannel of the micro reactor; v) reacting the reactive precursor with the isotope-containing solution as the reactive precursor and isotope-containing solution flow through the microchannel of the micro reactor, the reacting step resulting in formation of a radiochemical; and vi) collecting the radiochemical from the outlet port of the micro reactor.

Claims

1. A method for synthesizing a radiochemical in a microfluidic environment, the method comprising:

i) providing a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port;

ii) introducing a reactive precursor into the first inlet port of the micro reactor, the reactive precursor adapted for reaction with a radioactive isotope to form a radiochemical;

iii) introducing a solution comprising a radioactive isotope into the second inlet port of the micro reactor;

iv) contacting the reactive precursor with the isotope-containing solution in the microchannel of the micro reactor;

v) reacting the reactive precursor with the isotope-containing solution as the reactive precursor and isotope-containing solution flow through the microchannel of the micro reactor, said reacting step resulting in formation of a radiochemical; and

vi) collecting the radiochemical from the outlet port of the micro reactor.

2. The method of claim 1, wherein the radioactive isotope is dissolved in a polar aprotic solvent.

3. The method of claim 2, wherein the polar aprotic solvent is selected from the group consisting of acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), and hexamethylphosphoramide (HMPA).

4. The method of claim 1, wherein the radioactive isotope is selected from the group consisting of fluorine-18 fluoride, carbon-11, nitrogen-13, and oxygen-15.

5. The method of claim 1, wherein the radioactive isotope is fluorine-18 fluoride in the form of a coordination compound consisting of a phase transfer catalyst and salt complex.

6. The method of claim 1, wherein the reactive precursor is an organic molecule selected from the group consisting of sugars, amino acids, proteins, nucleosides, nucleotides, small molecule pharmaceuticals, and derivatives thereof.

7. The method of claim 1, wherein the reactive precursor is an organic molecule having the structure X—

R, wherein R is selected from the group consisting of alkyl, substituted alkyl, heterocycle, substituted heterocycle, aryl, substituted aryl, heteroaryl, and substituted heteroaryl, and X is a nucleophilic leaving group.

8. The method of claim 7, wherein X is a halogen or a pseudohalogen.

9. The method of claim 1, wherein the reactive precursor is dissolved in a polar aprotic solvent.

10. The method of claim 1, wherein the reactive precursor and the isotope-containing solution are moved through the micro reactor using at least one pump.

11. The method of claim 1, further comprising heating the reactive precursor and isotope-containing solution during said reacting step.

12. The method of claim 1, wherein the micro reactor comprises a first microchannel segment in fluid communication with the first inlet of the micro reactor, a second microchannel segment in fluid communication with the second inlet of the micro reactor, and a third microchannel segment in fluid communication with the outlet of the micro reactor, wherein the first, second and third microchannel segments intersect.

13. The method of claim 1, wherein the radiochemical collected from the micro reactor is selected from the group consisting of 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG), 6-[¹⁸F]fluoro-L-3,4-dihydroxyphenylalanine([¹⁸F]FDOPA), 6-[¹⁸F]fluoro-L-meta-tyrosine ([¹⁸F]FMT), 9-[4-[¹⁸F]fluoro-3-[¹⁸F]fluorocholine, [¹⁸F]fluoroethylcholine, 9-[4-[¹⁸F]fluoro-3-(hydroxymethyl)butyl]guanine([¹⁸F]FHBG), 9-[(3-[¹⁸F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([¹⁸F]FHPG), 3-(2′

-[¹⁸F]fluoroethyl)spiperone([¹⁸F]FESP), 3′

-deoxy-3′

-[¹⁸F]fluorothymidine([¹⁸F]FLT), 4-[¹⁸F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-benzamide([¹⁸F]p-MPPF), 2-(1-{6-[(2-[¹⁸F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidine)malononitrile([¹⁸F]FDDNP), 2-[¹⁸F]fluoro-α

-methyltyrosine, [¹⁸F]fluoromisonidazole([¹⁸F]FMISO), 5-[¹⁸F]fluoro-2′

-deoxyuridine([¹⁸F]FdUrd), [¹¹C]raclopride, [¹¹C]N-methylspiperone, [¹¹C]cocaine, [¹¹C]nomifensine, [¹¹C]deprenyl, [¹¹C]clozapine, [¹¹C]methionine, [¹¹C]choline, [¹¹C]thymidine, [¹¹C]flumazenil, [¹¹C]β

-aminoisobutyric acid ([¹¹Cβ

-AIBA), and other small physiologically-active molecules that are labeled using fluoride ion and protected forms thereof.

14. The method of claim 1, further comprising performing at least one additional method step in a microfluidic environment, the at least one additional method step being selected from the group consisting of deprotecting the radiochemical, purifying the radiochemical, and assaying radioactivity of the radiochemical.

15. A method for synthesizing a fluorine-18 fluoride labeled radiochemical in a microfluidic environment, the method comprising:

i) providing a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port;

ii) introducing a liquid organic reactive precursor dissolved in a polar aprotic solvent into the first inlet port of the micro reactor, the organic reactive precursor adapted for reaction with fluorine-18 fluoride to form a radiochemical;

iii) introducing a solution comprising fluorine-18 fluoride dissolved in a polar aprotic solvent into the second inlet port of the micro reactor;

iv) contacting the organic reactive precursor with the isotope-containing solution in the microchannel of the micro reactor;

v) reacting the organic reactive precursor with the fluorine-18 fluoride solution in a nucleophilic substitution reaction as the reactive precursor and fluorine-18 fluoride solution flow through the microchannel of the micro reactor, said reacting step resulting in formation of a fluorine-18 fluoride labeled radiochemical; and

vi) collecting the fluorine-18 fluoride labeled radiochemical from the outlet port of the micro reactor.

16. The method of claim 15, wherein said reacting step is conducted at a temperature of 65-100°

C.

17. The method of claim 15, wherein the polar aprotic solvent is selected from the group consisting of acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), and hexamethylphosphoramide (HMPA).

18. The method of claim 15, wherein the radioactive isotope is fluorine-18 fluoride in the form of a coordination compound consisting of a phase transfer catalyst and salt complex.

19. The method of claim 15, wherein the said reacting step is conducted where the water content, by weight, of the [¹⁸F] fluoride solution is 0.25% or less.

20. The method of claim 15, wherein the organic reactive precursor is selected from the group consisting of sugars, amino acids, proteins, nucleosides, nucleotides, small molecule pharmaceuticals, and derivatives thereof.

21. The method of claim 15, wherein the organic reactive precursor is an organic molecule having the structure X—

R, wherein R is selected from the group consisting of alkyl, substituted alkyl, heterocycle, substituted heterocycle, aryl, substituted aryl, heteroaryl, and substituted heteroaryl, and X is a nucleophilic leaving group.

22. The method of claim 21, wherein X is a halogen or a pseudohalogen.

23. The method of claim 15, wherein the organic reactive precursor and the fluorine-18 fluoride solution are moved through the micro reactor using at least one pump.

24. The method of claim 15, wherein the micro reactor comprises a first microchannel segment in fluid communication with the first inlet of the micro reactor, a second microchannel segment in fluid communication with the second inlet of the micro reactor, and a third microchannel segment in fluid communication with the outlet of the micro reactor, wherein the first, second and third microchannel segments intersect.

25. The method of claim 15, wherein the fluorine-18 fluoride labeled radiochemical collected from the micro reactor is selected from the group consisting of 2-deoxy-2-[¹⁸F]fluoro-D-glucose([¹⁸F]FDG), 6-[¹⁸F]fluoro-L-3,4-dihydroxyphenylalanine ([¹⁸F]FDOPA), 6-[¹⁸F]fluoro-L-meta-tyrosine([¹⁸F]FMT), 9-[4-[¹⁸F]fluoro-3-(hydroxymethyl)butyl]guanine([¹⁸F]FHBG), 9-[(3-[¹⁸F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([¹⁸F]FHPG), 3-(2′

-[¹⁸F]fluoroethyl)spiperone([¹⁸F]FESP), 3′

-deoxy-3′

-[¹⁸F]fluorothymidine([¹⁸F]FLT), 4-[¹⁸F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-benzamide([¹⁸F]p-MPPF), 2-(1-{6-[(2-[¹⁸F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidine)malononitrile([¹⁸F]FDDNP), 2-[¹⁸F]fluoro-α

-methyltyrosine, [¹⁸F]fluoromisonidazole([¹⁸F]FMISO), 5-[¹⁸F]fluoro-2′

-deoxyuridine([¹⁸F]FdUrd), and protected forms thereof.

26. The method of claim 15, wherein the fluorine-18 fluoride labeled radiochemical collected from the micro reactor is 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG),6-[¹⁸F]fluoro-L-3,4-dihydroxyphenylalanine([¹⁸F]FDOPA), or a protected form thereof.

27. The method of claim 15, further comprising performing at least one additional method step in a microfluidic environment, the at least one additional method step being selected from the group consisting of deprotecting the fluorine-18 fluoride labeled radiochemical, purifying the fluorine-18 fluoride labeled radiochemical, and assaying radioactivity of the fluorine-18 fluoride labeled radiochemical.

28. A system for synthesizing a radiochemical in a microfluidic environment, the system comprising:

a micro reactor comprising a first inlet port, a second inlet port, an outlet port, and at least one microchannel in fluid communication with the first and second inlet ports and the outlet port;

a supply of a reactive precursor in fluid communication with the first inlet port of the micro reactor, the reactive precursor adapted for reaction with a radioactive isotope to form a radiochemical; and

a supply of a solution comprising a radioactive isotope in fluid communication with the second inlet port of the micro reactor.

29. The system of claim 28, wherein the supply of isotope-containing solution comprises a solution of the radioactive isotope dissolved in a polar aprotic solvent.

30. The system of claim 29, wherein the polar aprotic solvent is selected from the group consisting of acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), and hexamethylphosphoramide (HMPA).

31. The method of claim 28, wherein the supply of isotope-containing solution is a solution of a radioactive isotope selected from the group consisting of fluorine-18 fluoride, carbon-11, nitrogen-13, and oxygen-15.

32. The system of claim 28, wherein the supply of isotope is fluorine-18 fluoride in the form of a coordination compound consisting of a phase transfer catalyst and salt complex.

33. The system of claim 28, wherein the supply of reactive precursor is a supply of an organic molecule selected from the group consisting of sugars, amino acids, proteins, nucleosides, nucleotides, small molecule drugs, and derivatives thereof.

34. The system of claim 33, wherein the reactive precursor is an organic molecule having the structure X—

R, wherein R is selected from the group consisting of alkyl, substituted alkyl, heterocycle, substituted heterocycle, aryl, substituted aryl, heteroaryl, and substituted heteroaryl, and X is a nucleophilic leaving group.

35. The system of claim 34, wherein X is a halogen or a pseudohalogen.

36. The system of claim 28, wherein the supply of reactive precursor is a supply of reactive precursor dissolved in a polar aprotic solvent.

37. The system of claim 28, further comprising at least one pump operatively positioned to propel the reactive precursor and the isotope-containing solution through the micro reactor.

38. The system of claim 37, comprising a first pump in fluid communication with said supply of reactive precursor and said first inlet of said micro reactor and a second pump in fluid communication with said supply of isotope-containing solution and said second inlet of said micro reactor.

39. The system of claim 28, further comprising a heat source operatively positioned to heat at least a portion of the micro reactor.

40. The system of claim 28, wherein said micro reactor is a microchip comprising a substrate having said at least one microchannel formed therein.

41. The system of claim 28, wherein said micro reactor comprises a length of capillary tubing defining said at least one microchannel.

42. The system of claim 28, wherein said micro reactor comprises a first microchannel segment in fluid communication with said first inlet of said micro reactor, a second microchannel segment in fluid communication with said second inlet of said micro reactor, and a third microchannel segment in fluid communication with said outlet of said micro reactor, wherein the first, second and third microchannel segments intersect.